![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LRRC57 |
Gene summary for LRRC57 |
![]() |
Gene information | Species | Human | Gene symbol | LRRC57 | Gene ID | 255252 |
Gene name | leucine rich repeat containing 57 | |
Gene Alias | LRRC57 | |
Cytomap | 15q15.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | A0A024R9M3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
255252 | LRRC57 | LZE4T | Human | Esophagus | ESCC | 8.75e-09 | 2.54e-01 | 0.0811 |
255252 | LRRC57 | LZE24T | Human | Esophagus | ESCC | 3.57e-08 | 1.14e-01 | 0.0596 |
255252 | LRRC57 | LZE21T | Human | Esophagus | ESCC | 1.26e-02 | 2.64e-01 | 0.0655 |
255252 | LRRC57 | P2T-E | Human | Esophagus | ESCC | 7.89e-18 | 1.99e-01 | 0.1177 |
255252 | LRRC57 | P4T-E | Human | Esophagus | ESCC | 6.98e-17 | 3.96e-01 | 0.1323 |
255252 | LRRC57 | P5T-E | Human | Esophagus | ESCC | 6.50e-16 | 2.07e-01 | 0.1327 |
255252 | LRRC57 | P8T-E | Human | Esophagus | ESCC | 2.80e-18 | 2.29e-01 | 0.0889 |
255252 | LRRC57 | P9T-E | Human | Esophagus | ESCC | 4.68e-05 | 1.27e-01 | 0.1131 |
255252 | LRRC57 | P10T-E | Human | Esophagus | ESCC | 5.22e-16 | 2.87e-01 | 0.116 |
255252 | LRRC57 | P11T-E | Human | Esophagus | ESCC | 2.70e-02 | 1.11e-01 | 0.1426 |
255252 | LRRC57 | P12T-E | Human | Esophagus | ESCC | 5.57e-17 | 3.80e-01 | 0.1122 |
255252 | LRRC57 | P15T-E | Human | Esophagus | ESCC | 5.31e-16 | 2.75e-01 | 0.1149 |
255252 | LRRC57 | P16T-E | Human | Esophagus | ESCC | 7.20e-14 | 2.83e-01 | 0.1153 |
255252 | LRRC57 | P20T-E | Human | Esophagus | ESCC | 3.30e-08 | 1.91e-01 | 0.1124 |
255252 | LRRC57 | P21T-E | Human | Esophagus | ESCC | 8.85e-19 | 2.75e-01 | 0.1617 |
255252 | LRRC57 | P22T-E | Human | Esophagus | ESCC | 5.63e-19 | 1.98e-01 | 0.1236 |
255252 | LRRC57 | P23T-E | Human | Esophagus | ESCC | 6.91e-06 | 2.34e-01 | 0.108 |
255252 | LRRC57 | P24T-E | Human | Esophagus | ESCC | 5.33e-06 | 1.20e-01 | 0.1287 |
255252 | LRRC57 | P26T-E | Human | Esophagus | ESCC | 4.62e-22 | 3.91e-01 | 0.1276 |
255252 | LRRC57 | P27T-E | Human | Esophagus | ESCC | 2.75e-13 | 1.94e-01 | 0.1055 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | ![]() |
Stomach | SIM | ![]() |
Liver | NAFLD | ![]() |
Liver | Cirrhotic | ![]() |
Liver | HCC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LRRC57 | SNV | Missense_Mutation | novel | c.106N>G | p.Leu36Val | p.L36V | Q8N9N7 | protein_coding | deleterious(0.04) | benign(0.352) | TCGA-A7-A4SE-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | CR |
LRRC57 | insertion | Nonsense_Mutation | novel | c.578_579insATATTTATCTTTCATGATAGACTAACTCTTTGAGGGCAAGG | p.Pro194TyrfsTer8 | p.P194Yfs*8 | Q8N9N7 | protein_coding | TCGA-AR-A0TY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | PD | ||
LRRC57 | SNV | Missense_Mutation | c.679N>C | p.Tyr227His | p.Y227H | Q8N9N7 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-CK-5916-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
LRRC57 | SNV | Missense_Mutation | rs762279497 | c.284A>G | p.Asn95Ser | p.N95S | Q8N9N7 | protein_coding | deleterious(0) | possibly_damaging(0.698) | TCGA-AG-3732-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | I/II | Chemotherapy | capecitabine | SD |
LRRC57 | SNV | Missense_Mutation | c.635T>A | p.Leu212His | p.L212H | Q8N9N7 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AH-6544-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | SD | |
LRRC57 | SNV | Missense_Mutation | rs762719937 | c.529N>T | p.Arg177Cys | p.R177C | Q8N9N7 | protein_coding | deleterious(0) | probably_damaging(0.92) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
LRRC57 | SNV | Missense_Mutation | c.431G>A | p.Arg144Gln | p.R144Q | Q8N9N7 | protein_coding | tolerated(0.49) | benign(0) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
LRRC57 | SNV | Missense_Mutation | novel | c.541N>A | p.Leu181Ile | p.L181I | Q8N9N7 | protein_coding | deleterious(0.02) | possibly_damaging(0.634) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
LRRC57 | SNV | Missense_Mutation | novel | c.42G>T | p.Gln14His | p.Q14H | Q8N9N7 | protein_coding | deleterious(0.01) | benign(0.275) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
LRRC57 | SNV | Missense_Mutation | novel | c.301N>T | p.Pro101Ser | p.P101S | Q8N9N7 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |